{
  "abstract": "Lower urinary tract symptoms (LUTSs) associated with benign prostatic disease and overactive bladder syndrome (OAB) substantially impair quality of life. This narrative review evaluates oxytocin receptor (OXTR) localisation, signalling, and contractile responses in prostate and bladder tissue, with anatomical and pharmacological context restricted to interpretation of these findings. Experimental receptor expression and antagonist responses provide mechanistic plausibility, but species differences, vasopressin receptor cross-reactivity, and inconsistent human tissue responses limit translation. Preclinical effects on tissue contractility and reproductive endpoints are distinguished from clinical urinary outcomes. OXTR antagonism remains investigational for LUTSs and OAB; clinical efficacy and safety require validation. Proposed artificial intelligence applications are limited to experimental receptor localisation, contraction analysis, and phenotyping.",
  "abstract_shown": true,
  "affiliations": [
    "Hudson Institute of Medical Research, , Clayton, VIC 3168, Australia",
    "Monash Institute of Pharmaceutical Sciences, , Parkville, VIC 3052, Australia",
    "Department of Pharmaceutical Sciences, College of Pharmacy, , Riyadh 11533, Saudi Arabia",
    "Institute of Anatomy and Cell Biology, Justus-Liebig-University, 35390 Giessen, Germany"
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Masroor Badshah"
    },
    {
      "affs": [
        1
      ],
      "name": "Jibriil Ibrahim"
    },
    {
      "affs": [
        2
      ],
      "name": "Khaled A. Elnahriry"
    },
    {
      "affs": [
        3
      ],
      "name": "Ralf Middendorff"
    },
    {
      "affs": [
        1
      ],
      "name": "Michael Whittaker"
    },
    {
      "affs": [
        1
      ],
      "name": "Betty Exintaris"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/5kdvarx0vmjp0.bib",
  "cited_by": 0,
  "doi": "10.3390/biomedicines14102306",
  "fulltext_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13702364/?tool=EBI",
  "id": "5kdvarx0vmjp0",
  "issns": [
    "2227-9059"
  ],
  "landing_url": "https://europepmc.org/article/PMC/PMC13702364",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "QH301-705.5"
    ],
    [
      "openalex",
      "2748|Urinary Bladder and Prostate Research"
    ]
  ],
  "openalex": "W7221547555",
  "pdf_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13702364/pdf/?tool=EBI",
  "pmcid": "PMC13702364",
  "pmid": null,
  "published": "2026-10-01",
  "publisher": "MDPI AG",
  "ris": "https://research.draconitic.com/paper/5kdvarx0vmjp0.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:21:34Z",
      "native_id": "PMC:PMC13702364",
      "source": "europepmc",
      "url": "https://europepmc.org/article/PMC/PMC13702364"
    },
    {
      "first_seen": "2026-10-31T14:21:22Z",
      "native_id": "00457649dc264eea9bc7a2a078c0d5b0",
      "source": "doaj",
      "url": "https://doi.org/10.3390/biomedicines14102306"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2748|Urinary Bladder and Prostate Research",
      "subfield": "general"
    }
  ],
  "title": "Oxytocin Signalling in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia and Overactive Bladder Syndrome: A Narrative Review",
  "title_text": "Oxytocin Signalling in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia and Overactive Bladder Syndrome: A Narrative Review",
  "type": "peer-reviewed",
  "updated_at": "2026-10-31T14:21:22Z",
  "url": "https://research.draconitic.com/paper/5kdvarx0vmjp0",
  "venue": "Biomedicines",
  "versions": []
}